Canadian Health Coalition
  • Donate
  • Menu Canvas
    • CHC Home
    • News
    • About us
    • Campaigns
    • Contact
  • hello@healthcoalition.ca
  • 613-699-9898
Donate OR Subscribe
    • English
Canadian Health Coalition
  • Home
  • About us
    • Our Team
  • News
  • Campaigns
  • Contact
  • Donate

    Support the Canadian Health Coalition

    $
    Select Payment Method
    Personal Info

    Credit Card Info
    This is a secure SSL encrypted payment.

    Donation Total: $25.00 One Time

How did “Big Pharma” delay cheaper drug prices, again?

Homepage Analysis How did “Big Pharma” delay cheaper drug prices, again?
Analysis

How did “Big Pharma” delay cheaper drug prices, again?

January 24, 2022
By CDN Health Coalition
0 Comment
501 Views

It was the day before Christmas Eve when the government issued a statement from Health Minister Jean-Yves Duclos announcing delays to widely anticipated drug pricing changes.

“As the global impact of the COVID-19 pandemic persists and new variants of concern emerge that require urgent action, the Government of Canada is delaying the coming-into-force of the Regulations Amending the Patented Medicines Regulations by six months. These regulations will now come into force on July 1, 2022.”

Health Minister Jean-Yves Duclos

Drug company lobbyists and their benefactors were clinking glasses all over Ottawa celebrating the early gift: new rules intended to lower drug process paid by Canadians and their governments were delayed once again.

It was the fourth delay since efforts to change the rules to reduce drug costs were started five years ago.

Pharmaceutical expert Dr. Joel Lexchin, a member of the Canadian Health Coalition’s Board of Directors, has published a new paper detailing the extensive lobbying done by drug companies to block the government’s attempts to get drug prices under control.

His new latest paper published by The Conversation this week, is titled “Lower drug prices are a priority for Canadians, but not for the federal government.”

“Lower drug prices are a priority for Canadians, but not for the federal government.”

DR. JOEL LEXCHIN

He argues that the “Big Pharma” lobby, some drug-company-funded advocacy groups, a few doctors, and even U.S. government agencies and industry lobby groups have worked the Liberals hard. The delays are impacting Canadians’ wallets and their health.

“While the federal government has been bowing to the pharmaceutical industry, the amount that Canadians spend on medicines has continued to rise,” writes Dr. Lexchin. Citing research done by the Canadian Federation of Nurses Unions, he adds, “The lack of affordability of prescription drugs could be causing 370 to 640 premature deaths due to heart disease every year.”

  • Read “Lower drug prices are a priority for Canadians, but not for the federal government” by Dr. Joel Lexchin, published on January 24, 2022 by The Conversation.com.

Tags: Pharmacare

Previous Story
Unifor launches “Vaccine Access for All” petition
Next Story
NUPGE report warns against privatization through virtual health care

Related Articles

Canadians want it, doctors want it, so let’s get pharmacare done

1,000 experts sign petition to Canada’s Prime Minister

Doing pharmacare with Don Davies MP, Brendan Hanley MP and Linda Silas, CFNU

A special presentation by the Pearson Centre for Progressive Policy,...

Recent Posts

  • Québec Coroner calls for “deprivatization” of long-term care facilities May 18, 2022
  • Health Coalition team expands with the addition of two new staff members May 18, 2022
  • Canadians want it, doctors want it, so let’s get pharmacare done May 11, 2022
  • More federal funding needed to end troubling backlogs, says Health Coalition May 11, 2022
  • Results of elections could determine the future of the care economy, says Care Economy Group May 4, 2022

Tags

Canada Health Transfer Canadian Health Coalition COVID-19 Federal Election 44 Health care workers Health policy Long-term care Mental health Pharmacare Privatization Racism

Cdn Health CoalitionFollow

Cdn Health Coalition

Report: Careless Profits: Diverting public money from long-term care in Ontario https://www.taxfairness.ca/en/resource/report-careless-profits-diverting-public-money-long-term-care-ontario

Reply on Twitter 1527309664936988672Retweet on Twitter 15273096649369886722Like on Twitter 15273096649369886722
Canadian Health Coalition
116 Albert St. Suite 300
Ottawa, Ontario K1P 5G3
+613.699.9898
hello@healthcoalition.ca
  • Home
  • What we do
  • Campaigns
  • News
  • Contact

Find posts prior to January 1, 2021
SearchPostsLogin
Wednesday, 18, May
Québec Coroner calls for “deprivatization” of long-term care facilities
Wednesday, 18, May
Health Coalition team expands with the addition of two new staff members
Wednesday, 11, May
Canadians want it, doctors want it, so let’s get pharmacare done
Wednesday, 11, May
More federal funding needed to end troubling backlogs, says Health Coalition
Wednesday, 4, May
Results of elections could determine the future of the care economy, says Care Economy Group
Thursday, 28, Apr
Doing pharmacare with Don Davies MP, Brendan Hanley MP and Linda Silas, CFNU

Welcome back,